Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:20452823rdf:typepubmed:Citationlld:pubmed
pubmed-article:20452823lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:20452823lifeskim:mentionsumls-concept:C0087111lld:lifeskim
pubmed-article:20452823lifeskim:mentionsumls-concept:C0008976lld:lifeskim
pubmed-article:20452823lifeskim:mentionsumls-concept:C0030567lld:lifeskim
pubmed-article:20452823lifeskim:mentionsumls-concept:C0086132lld:lifeskim
pubmed-article:20452823lifeskim:mentionsumls-concept:C0074710lld:lifeskim
pubmed-article:20452823pubmed:issue6lld:pubmed
pubmed-article:20452823pubmed:dateCreated2010-5-24lld:pubmed
pubmed-article:20452823pubmed:databankReferencehttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20452823pubmed:abstractTextDepression is common in patients with Parkinson's disease, but evidence on the efficacy of antidepressants in this population is lacking. Because depression in patients with Parkinson's disease might be related to dopaminergic dysfunction, we aimed to assess the efficacy of the dopamine agonist pramipexole for treatment of depressive symptoms in patients with Parkinson's disease.lld:pubmed
pubmed-article:20452823pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20452823pubmed:languageenglld:pubmed
pubmed-article:20452823pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20452823pubmed:citationSubsetIMlld:pubmed
pubmed-article:20452823pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20452823pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20452823pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20452823pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20452823pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20452823pubmed:statusMEDLINElld:pubmed
pubmed-article:20452823pubmed:monthJunlld:pubmed
pubmed-article:20452823pubmed:issn1474-4465lld:pubmed
pubmed-article:20452823pubmed:authorpubmed-author:RascolOlivier...lld:pubmed
pubmed-article:20452823pubmed:authorpubmed-author:PoeweWernerWlld:pubmed
pubmed-article:20452823pubmed:authorpubmed-author:BaronePaoloPlld:pubmed
pubmed-article:20452823pubmed:authorpubmed-author:TolosaEduardo...lld:pubmed
pubmed-article:20452823pubmed:authorpubmed-author:WeintraubDani...lld:pubmed
pubmed-article:20452823pubmed:authorpubmed-author:MasseyDanDlld:pubmed
pubmed-article:20452823pubmed:authorpubmed-author:DebieuvreCath...lld:pubmed
pubmed-article:20452823pubmed:authorpubmed-author:AlbrechtStefa...lld:pubmed
pubmed-article:20452823pubmed:copyrightInfoCopyright 2010 Elsevier Ltd. All rights reserved.lld:pubmed
pubmed-article:20452823pubmed:issnTypeElectroniclld:pubmed
pubmed-article:20452823pubmed:volume9lld:pubmed
pubmed-article:20452823pubmed:ownerNLMlld:pubmed
pubmed-article:20452823pubmed:authorsCompleteYlld:pubmed
pubmed-article:20452823pubmed:pagination573-80lld:pubmed
pubmed-article:20452823pubmed:dateRevised2011-5-16lld:pubmed
pubmed-article:20452823pubmed:meshHeadingpubmed-meshheading:20452823...lld:pubmed
pubmed-article:20452823pubmed:meshHeadingpubmed-meshheading:20452823...lld:pubmed
pubmed-article:20452823pubmed:meshHeadingpubmed-meshheading:20452823...lld:pubmed
pubmed-article:20452823pubmed:meshHeadingpubmed-meshheading:20452823...lld:pubmed
pubmed-article:20452823pubmed:meshHeadingpubmed-meshheading:20452823...lld:pubmed
pubmed-article:20452823pubmed:meshHeadingpubmed-meshheading:20452823...lld:pubmed
pubmed-article:20452823pubmed:meshHeadingpubmed-meshheading:20452823...lld:pubmed
pubmed-article:20452823pubmed:meshHeadingpubmed-meshheading:20452823...lld:pubmed
pubmed-article:20452823pubmed:meshHeadingpubmed-meshheading:20452823...lld:pubmed
pubmed-article:20452823pubmed:meshHeadingpubmed-meshheading:20452823...lld:pubmed
pubmed-article:20452823pubmed:meshHeadingpubmed-meshheading:20452823...lld:pubmed
pubmed-article:20452823pubmed:meshHeadingpubmed-meshheading:20452823...lld:pubmed
pubmed-article:20452823pubmed:meshHeadingpubmed-meshheading:20452823...lld:pubmed
pubmed-article:20452823pubmed:meshHeadingpubmed-meshheading:20452823...lld:pubmed
pubmed-article:20452823pubmed:meshHeadingpubmed-meshheading:20452823...lld:pubmed
pubmed-article:20452823pubmed:meshHeadingpubmed-meshheading:20452823...lld:pubmed
pubmed-article:20452823pubmed:meshHeadingpubmed-meshheading:20452823...lld:pubmed
pubmed-article:20452823pubmed:meshHeadingpubmed-meshheading:20452823...lld:pubmed
pubmed-article:20452823pubmed:year2010lld:pubmed
pubmed-article:20452823pubmed:articleTitlePramipexole for the treatment of depressive symptoms in patients with Parkinson's disease: a randomised, double-blind, placebo-controlled trial.lld:pubmed
pubmed-article:20452823pubmed:affiliationDepartment of Neurological Sciences, University of Naples Federico II and IDC Hermitage Capodimonte, Naples, Italy. barone@unina.itlld:pubmed
pubmed-article:20452823pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:20452823pubmed:publicationTypeRandomized Controlled Triallld:pubmed
pubmed-article:20452823pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
pubmed-article:20452823pubmed:publicationTypeMulticenter Studylld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:20452823lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:20452823lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:20452823lld:pubmed